The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Sitagliptin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus
- Focus Pharmacodynamics
- 01 Mar 2018 Planned End Date changed from 1 Jan 2018 to 1 Jul 2019.
- 01 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 May 2018.
- 04 Jan 2018 Status changed from recruiting to active, no longer recruiting.